ÍøºìºÚÁÏ

The goal of this Phase 2 clinical trial is to investigate the efficacy and safety of NEU-411 in men and women aged 40-80 years with early Parkinson's Disease (PD) who have predicted elevations in the activity of the "leucine-rich repeat kinase 2"…

Investigator

Adolfo Ramirez-Zamora

Ages

40 Years - 80 Years

Sexes

All

Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement. The…

Investigator

Irene A Malaty

Ages

18 Years - N/A

Sexes

All

This study is a Phase 3 multi-site, randomized, evaluator-masked, study of endurance treadmill exercise on changes in the Movement Disorder Society-Unified Parkinson Disease Rating Scale (MDS-UPDRS) Part III score at 12 months among persons with…

Ages

40 Years - 80 Years

Sexes

All